Return to homepagePandemic Pact

Rational design of a new range of Covid-19 nanobodies to generate first line therapies effective against new variants. Jim Naimsith. Rosalind Franklin Istitute and Protein Production UK

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-439

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Jim Naismith

  • Research Location

    United Kingdom

  • Lead Research Institution

    Research Complex at Harwell

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract